Phase 3 Randomized Trial Of PSMA PET Prior to Definitive Radiation Therapy for Unfavorable Intermediate-Risk or High-Risk Prostate Cancer [PSMA dRT]
Latest Information Update: 07 Mar 2024
At a glance
- Drugs Piflufolastat F18 (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- Acronyms PSMA dRT
- 27 Jan 2024 Results presented at the 2024 Genitourinary Cancers Symposium
- 12 Jan 2023 Status changed from active, no longer recruiting to discontinued.
- 10 Feb 2022 Status changed from recruiting to active, no longer recruiting.